KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Capital Employed (2016 - 2025)

Rigel Pharmaceuticals (RIGL) has 15 years of Return on Capital Employed data on record, last reported at 0.91% in Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 79.0% year-over-year to 0.91%; the TTM value through Sep 2025 reached 0.91%, up 79.0%, while the annual FY2024 figure was 0.31%, 60.0% up from the prior year.
  • Return on Capital Employed reached 0.91% in Q3 2025 per RIGL's latest filing, down from 1.0% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 1.0% in Q2 2025 and bottomed at 1.06% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.18%, with a median of 0.13% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: tumbled -99bps in 2022, then surged 113bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.11% in 2021, then tumbled by -744bps to 0.93% in 2022, then soared by 65bps to 0.33% in 2023, then skyrocketed by 184bps to 0.27% in 2024, then surged by 234bps to 0.91% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.91% in Q3 2025, 1.0% in Q2 2025, and 0.43% in Q1 2025.